APOA1 and metabolic syndrome: The levels of ApoA1 in serum were significantly reduced in patients with Sch receiving APs compared with healthy people (p-value = 0.002), while a decrease in serum ApoA1 was also determined in patients with MetS, but these results did not have a high level of significance [218].